USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Synaptive Medical Inc.

USPTO PatentsView assignee record - 141 granted patents across 39 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

141

Total patents granted

CPC technology areas

16.8

Avg claims per patent

5-year filing velocity

The verdict

Synaptive holds 141 US patents across 39 technology areas, rank #2,748 of 50,000 tracked assignees.

#2,748
of 50,000 US assignees by volume: Top 2%
by Innovation Score (62.3/100): 16.8
avg claims per patent

Portfolio overview

Synaptive Medical Inc. has been granted 141 US utility patents between 2020 and 2025, placing Synaptive Medical Inc. at rank #2,748 across all assignees tracked by PlainPatent. This portfolio spans 39 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Synaptive Medical Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Synaptive sits between Laird Technologies, Inc. (141 patents, rank #2,744) and Amicus Therapeutics, Inc. (140 patents, rank #2,752) - the closest US assignees by grant volume. The composite Innovation Score of 62.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 141 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Synaptive Medical Inc.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 39 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Synaptive Medical Inc. against peers pursuing similar technology classes.

Laird

141
Marathon Petroleum

141
Nxstage Medical

141
Optis Wireless Te…

141
Therabody

141
Tomtom Internatio…

141
Synaptive Medical ◀

141
AMBU A/S

140
Amicus Therapeuti…

140

What this shows Synaptive holds 141 patents at rank #2,748, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Synaptive

By rank, the assignees closest to #2,748 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Synaptive's primary technology class.

Synaptive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Synaptive Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	0.7%
2021	46	32.6%
2022	35	24.8%
2023	44	31.2%
2024	13	9.2%
2025	2	1.4%

Which technologies does Synaptive Medical Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 101

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 59

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 26

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 21

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 17

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 15

G06F - ELECTRIC DIGITAL DATA PROCESSING 7

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES 7

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 5

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 4

G01B - MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS 3

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 2

G01V - GEOPHYSICS; GRAVITATIONAL MEASUREMENTS; DETECTING MASSES OR OBJECTS; TAGS 2

Top 15 of 39 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Where it ranks

Overall rank by patents

#2,748

Across all tracked assignees

Innovation Score

62.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Synaptive Medical Inc. hold?

Synaptive Medical Inc. holds 141 US granted patents filed between 2020 and 2025, spanning 39 technology areas.

What is Synaptive Medical Inc.'s Innovation Score?

Synaptive Medical Inc. has an Innovation Score of 62.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Synaptive Medical Inc. focus on?

Synaptive Medical Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 101 patents. The company has filed patents in 39 CPC subclasses total.

Is Synaptive Medical Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Synaptive Medical Inc..

What does claim depth mean for Synaptive Medical Inc.'s patents?

Synaptive Medical Inc.'s patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Synaptive Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Synaptive's 141 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Synaptive ranks #2,748 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.